{"id":758461,"date":"2023-05-12T08:42:10","date_gmt":"2023-05-12T12:42:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\/"},"modified":"2023-05-12T08:42:10","modified_gmt":"2023-05-12T12:42:10","slug":"morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\/","title":{"rendered":"Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">WALTHAM, Mass., May  12, 2023  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iGXKw8A9tEyxyUKzPbMtte1g9Tg1-q4N47oiEgbdSoet1WRn6n5LoZFRlLhinSi5psWuFP0-41QNzpWPNPkAEQ==\" rel=\"nofollow noopener\" target=\"_blank\">Morphic Therapeutic<\/a> (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that its management team will participate in a Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference on Wednesday, May 17, 2023.<\/p>\n<p align=\"justify\">\n        <strong>Fireside Chat Information<\/strong><br \/>\n        <br \/>Date: Wednesday May 17, 2023<br \/>Time: 10:30 AM ET<br \/>A live webcast of the presentations will be available on the Investor section of the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iGXKw8A9tEyxyUKzPbMttTBNLCHlwR3sRGCy435A-64fAE52OwRq-oCad2tmzTz-0yPEQSy3abnCL9Wkifvxlw==\" rel=\"nofollow noopener\" target=\"_blank\">Morphic website<\/a>. An archived replay will be available on the company\u2019s website following the conference.<\/p>\n<p align=\"justify\">\n        <strong>About Morphic Therapeutic<\/strong><br \/>\n        <br \/>Morphic Therapeutic is a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer. Morphic is also advancing its pipeline and discovery activities in collaboration with Schr\u00f6dinger using its proprietary MInT technology platform which leverages the Company\u2019s unique understanding of integrin structure and biology. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VHQ3-0Y3tK9ELTB4cmF5VxPzd3mMDK-4fhhEqSMF5PrI5nIf5GvQfQbERzf08eI1uj90WglgCOt77ZC7ybBf4w==\" rel=\"nofollow noopener\" target=\"_blank\">www.morphictx.com<\/a>.<\/p>\n<p align=\"left\">\n        <strong>Contacts<\/strong><br \/>\n        <br \/>Morphic Therapeutic<br \/>Chris Erdman<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_jw_omXc_Cah_4UMqM2yFvwzBQ9c9P5wZBDs7uHX9owEsyrrdm5Ew8K3QzfmGY1g9WXbfuqwrBESMaCgrx1W3ZeKPZRfTQPoAcG2fqHrXBhUz_UC4Ri_6gVR7J7mr1vP\" rel=\"nofollow noopener\" target=\"_blank\">chris.erdman@morphictx.com<\/a><br \/>617.686.1718<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzODMzMiM1NTkyNTMxIzIxODc0MzU=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/M2Y0MjhiZGMtYjdmZC00ZTg2LTllMTItOWFjMzFkYmJkODA3LTExOTg5ODg=\/tiny\/Morphic-Therapeutic.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WALTHAM, Mass., May 12, 2023 (GLOBE NEWSWIRE) &#8212; Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that its management team will participate in a Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference on Wednesday, May 17, 2023. Fireside Chat Information Date: Wednesday May 17, 2023Time: 10:30 AM ETA live webcast of the presentations will be available on the Investor section of the Morphic website. An archived replay will be available on the company\u2019s website following the conference. About Morphic Therapeutic Morphic Therapeutic is a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment of serious chronic diseases, including &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-758461","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass., May 12, 2023 (GLOBE NEWSWIRE) &#8212; Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that its management team will participate in a Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference on Wednesday, May 17, 2023. Fireside Chat Information Date: Wednesday May 17, 2023Time: 10:30 AM ETA live webcast of the presentations will be available on the Investor section of the Morphic website. An archived replay will be available on the company\u2019s website following the conference. About Morphic Therapeutic Morphic Therapeutic is a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment of serious chronic diseases, including &hellip; Continue reading &quot;Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-12T12:42:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzODMzMiM1NTkyNTMxIzIxODc0MzU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference\",\"datePublished\":\"2023-05-12T12:42:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\\\/\"},\"wordCount\":179,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzODMzMiM1NTkyNTMxIzIxODc0MzU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\\\/\",\"name\":\"Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzODMzMiM1NTkyNTMxIzIxODc0MzU=\",\"datePublished\":\"2023-05-12T12:42:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzODMzMiM1NTkyNTMxIzIxODc0MzU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzODMzMiM1NTkyNTMxIzIxODc0MzU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference - Market Newsdesk","og_description":"WALTHAM, Mass., May 12, 2023 (GLOBE NEWSWIRE) &#8212; Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that its management team will participate in a Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference on Wednesday, May 17, 2023. Fireside Chat Information Date: Wednesday May 17, 2023Time: 10:30 AM ETA live webcast of the presentations will be available on the Investor section of the Morphic website. An archived replay will be available on the company\u2019s website following the conference. About Morphic Therapeutic Morphic Therapeutic is a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment of serious chronic diseases, including &hellip; Continue reading \"Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-12T12:42:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzODMzMiM1NTkyNTMxIzIxODc0MzU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference","datePublished":"2023-05-12T12:42:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\/"},"wordCount":179,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzODMzMiM1NTkyNTMxIzIxODc0MzU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\/","name":"Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzODMzMiM1NTkyNTMxIzIxODc0MzU=","datePublished":"2023-05-12T12:42:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzODMzMiM1NTkyNTMxIzIxODc0MzU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzODMzMiM1NTkyNTMxIzIxODc0MzU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-to-present-at-2023-rbc-capital-markets-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/758461","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=758461"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/758461\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=758461"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=758461"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=758461"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}